Related references
Note: Only part of the references are listed.Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer
Alastair M. Thompson
CLINICAL CANCER RESEARCH (2014)
Human Insulin Does Not Increase Bladder Cancer Risk
Chin-Hsiao Tseng
PLOS ONE (2014)
Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
Chin-Hsiao Tseng
ANNALS OF MEDICINE (2013)
Metformin and cancer
Christos V. Rizos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Pioglitazone does not affect the risk of ovarian cancer: Analysis of a nationwide reimbursement database in Taiwan
Chin-Hsiao Tseng
GYNECOLOGIC ONCOLOGY (2013)
Clinical Studies Examining the Impact of Obesity on Breast Cancer Risk and Prognosis
Rishi Jain et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2013)
New-Onset Diabetes With a History of Dyslipidemia Predicts Pancreatic Cancer
Chin-Hsiao Tseng
PANCREAS (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how?
X. L. Yang et al.
DIABETES OBESITY & METABOLISM (2012)
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
Kiyohito Kato et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
Emily Jane Gallagher et al.
YEAR IN DIABETES AND OBESITY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Development of a prognostic nomogram for identifying those factors which influence the 2-and 5-year survival chances of Taiwanese women diagnosed with breast cancer
Y-P. Fan et al.
EUROPEAN JOURNAL OF CANCER CARE (2011)
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies
B. H. Ch. Stricker et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Cancer Trends in Taiwan
Chun-Ju Chiang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Bias: Considerations for research practice
Tobias Gerhard
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
